Join Free For Buyer|Sign In
CPhI&P-MEC

Professional Online Trade Platform for API, Preparation and Pharmaceutical Machinery and Equipment_EN-CPhI.cn

2018NEX

You are here:Home >> product >> Active Pharmaceutical Ingredients >> Other Active Pharmaceutical Ingredients >> Telaprevir

Telaprevir

Telaprevir

Region: Jiangsu
Minimum Order Quantity:
Monthly Production Capacity:
Send Inquiry Add to Cart
Detailed Description
  • Main Sales Markets: North America, Central/South America, Western Europe, Eastern Europe, Australasia, Asia, Middle East, Africa
  • Sample Provided: no

Telaprevir (VX-950), marketed under the brand names Incivek and Incivo, is a pharmaceutical drug for the treatment of hepatitis C codeveloped by Vertex Pharmaceuticals and Johnson & Johnson. It is a member of a class of antiviral drugs known as protease inhibitors.[3] Specifically, telaprevir inhibits the hepatitis C viral enzyme NS3.4A serine protease.[4] Telaprevir is only indicated for use against hepatitis C genotype 1 viral infections and has not been proven to have an effect on or being safe when used for other genotypes of the virus. The standard therapy of pegylated interferon and ribavirin is less effective on genotype 1.

Address: Taizhou,Jiangsu,China

City: Taizhou

Contact: Chen Bin

TEL: -523-86818997

Fax: -523-86818697

Send Inquiry
Previous Other Active Pharmaceutical Ingredients Next
Follow Us
CPhI Online Trade Platform: Worldwide|English|中国站
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)
About Us| Contact Us| Terms of Services| Privacy Policy| Intellectual Property Statement| Links | Site Map
Copyright 2006-20 Shanghai UBM Sinoexpo International Exhibition Co Ltd (All Rights Reserved). ICP 05034851-53